1,098 reports of this reaction
1.8% of all BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE reports
#11 most reported adverse reaction
DRUG ABUSE is the #11 most commonly reported adverse reaction for BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, manufactured by INDIVIOR INC.. There are 1,098 FDA adverse event reports linking BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE to DRUG ABUSE. This represents approximately 1.8% of all 59,605 adverse event reports for this drug.
Patients taking BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE who experience drug abuse should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG ABUSE is a less commonly reported adverse event for BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, but still significant enough to appear in the safety profile.
In addition to drug abuse, the following adverse reactions have been reported for BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE:
The following drugs have also been linked to drug abuse in FDA adverse event reports:
DRUG ABUSE has been reported as an adverse event in 1,098 FDA reports for BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG ABUSE accounts for approximately 1.8% of all adverse event reports for BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, making it a notable side effect.
If you experience drug abuse while taking BUPRENORPHINE HYDROCHLORIDE, NALOXONE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.